Progyny, Inc. cash flow statement

In fiscal 2025, Progyny, Inc.'s operations generated $210m of cash; it spent $18.4m on capital projects, leaving free cash flow of $192m. It returned $81.7m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Progyny, Inc.: cash flow statement, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash from operations	−9	2	−2	36	26	80	189	179	210	201
Depreciation and amortisation	2	2	2	2	1	2	2	3	5	6
Stock-based pay	2	3	5	13	34	101	123	128	132	107
Capital spending	1	1	3	1	2	3	4	5	18	23
Free cash flow	−10	2	−4	35	24	77	185	174	192	178
Free cash flow after stock pay	−12	−1	−10	22	−10	−24	63	46	60	71
Share buybacks	—	1	0	—	—	0	0	300	82	230

US$ millions unless shown otherwise. Fiscal quarters.

Progyny, Inc.: cash flow statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Cash from operations	45	52	50	56	51	54	46	50
Depreciation and amortisation	1	1	1	1	1	1	1	2
Stock-based pay	33	31	33	32	32	35	20	20
Capital spending	2	2	3	5	5	6	6	6
Free cash flow	43	50	47	50	46	49	40	44
Free cash flow after stock pay	10	19	14	18	14	14	20	24

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: HQY vs PGNY GH vs PGNY ADUS vs PGNY PGNY vs PIII

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Progyny, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Progyny, Inc.